Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Glucose Transporter Type 1 Deficiency SyndromeGLUT1DS1
Interventions
OTHER

Red Blood Cell Transfusion

The procedure will be performed as an outpatient according to protocols established for sickle cell anemia patients. Two IVs are placed for the purposes of transfusion, one for draw and one for return. Patients will undergo isovolemic hemodilution-red cell exchange (IHD- RBCx) with up to 10 units of red cell antigens (Rh group, Kell, Duffy, Kidd blood group antigens) matched normal donor red cells to replace a target of 70% of the patient's red cells with donor red cells.Total time of procedure: approximately 150 minutes.

Trial Locations (1)

75390

UT Southwestern, Dallas

All Listed Sponsors
lead

Juan Pascual

OTHER